Journal: International Journal of Molecular Sciences

Article Title: TNF-α Affects Signature Cytokines of Th1 and Th17 T Cell Subsets through Differential Actions on TNFR1 and TNFR2

doi: 10.3390/ijms23169306

Figure Lengend Snippet: TNF-α does not impact the levels of TNFR1 and TNFR2 on Th1 and Th17 cells. Purified CD4 + T cell subsets were stimulated with 1 µg/mL of TNF-α for 24 h and stained, for flow cytometry, with anti-human TNFR1 or TNFR2 mAbs. ( A ) Representative histograms showing the expression levels of TNFR1 and TNFR2 on Th1 and Th17 cells at baseline conditions and upon TNF-α stimulus. Solid black line histograms, isotype control; black histograms, Th1 cells; grey histograms, Th17 cells; dashed line histograms, TNF-α-treated Th1 cells; long dashed line histograms, TNF-α-treated Th17 cells. The levels of TNFR1 ( B ) and TNFR2 ( C ) were measured on purified CD4 + T cell subpopulations obtained from two to four healthy controls. Bars represent the mean values ± SD. Statistical analyses were carried out with Kruskal–Wallis followed by Dunn’s multiple comparison tests. ** p < 0.01.

Article Snippet: Cells were then stained with a mouse anti-human TNFR1-APC mAb (clone 16803) (R&D Systems, Minneapolis, MN, USA) and a rat anti-human TNFR2-PE mAb (clone hTNFR-M1) (BD Biosciences) for 30 min at 4 °C in the dark.

Techniques: Purification, Staining, Flow Cytometry, Expressing, Control, Comparison

Journal: International Journal of Molecular Sciences

Article Title: TNF-α Affects Signature Cytokines of Th1 and Th17 T Cell Subsets through Differential Actions on TNFR1 and TNFR2

doi: 10.3390/ijms23169306

Figure Lengend Snippet: Effect of TNFR1 or TNFR2 blockade on the production of IFN-γ and IL-17 by Th1 and Th17 cells. Purified CD4 + T lymphocyte subpopulations were incubated with neutralizing antibodies to TNFR1 or TNFR2 for 1 h prior to a 4-day stimulus with TNF-α (1 µg/mL). Intracellular staining of IFN-γ and IL-17 was assessed by flow cytometry. ( A ) Representative dot plots of Th1 and Th17 cells treated with anti-TNFR1 or anti-TNFR2 in the presence or absence of TNF-α. An isotype control was used to discard non-specific effects of the neutralizing antibodies. The fold increase in the percentages of IFN-γ ( B , D ) or IL-17 ( C , E ) producers was measured on Th1 and Th17 cells obtained from two to six healthy donors. Bars represent the mean values ± SD. Data were normalized against cells that did not receive treatment with TNF-α or TNF-α plus TNFRs blocking mAbs. For statistical analysis, Kruskal–Wallis and Dunn’s multiple comparison tests were performed. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Cells were then stained with a mouse anti-human TNFR1-APC mAb (clone 16803) (R&D Systems, Minneapolis, MN, USA) and a rat anti-human TNFR2-PE mAb (clone hTNFR-M1) (BD Biosciences) for 30 min at 4 °C in the dark.

Techniques: Purification, Incubation, Staining, Flow Cytometry, Control, Blocking Assay, Comparison

Journal: International Journal of Molecular Sciences

Article Title: TNF-α Affects Signature Cytokines of Th1 and Th17 T Cell Subsets through Differential Actions on TNFR1 and TNFR2

doi: 10.3390/ijms23169306

Figure Lengend Snippet: Expression of TNFR1 and TNFR2 on Th1 and Th17 cells present in the peripheral blood of rheumatoid arthritis (RA) patients treated with adalimumab. Cell staining for flow cytometry analysis was performed on PBMC samples from healthy controls ( n = 9) and RA patients ( n = 10) before (PRE) and after (POST) treatment with adalimumab. The levels of TNFR1 ( A ) and TNFR2 ( C ) are expressed in MFI values. The frequency of TNFR1 ( B ) and TNFR2 ( D )-expressing lymphocytes are also shown. Each symbol represents data for one individual. Mean values ± SD are indicated. Significance was assessed with non-parametric Kruskal–Wallis test followed by Dunn’s multiple comparison test (for MFI data) or parametric one-way ANOVA plus Tukey’s post-test (for lymphocyte frequencies data). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

Article Snippet: Cells were then stained with a mouse anti-human TNFR1-APC mAb (clone 16803) (R&D Systems, Minneapolis, MN, USA) and a rat anti-human TNFR2-PE mAb (clone hTNFR-M1) (BD Biosciences) for 30 min at 4 °C in the dark.

Techniques: Expressing, Staining, Flow Cytometry, Comparison

Journal: Hepatology Communications

Article Title: Activation of Liver X Receptor α Sensitizes Mice to T‐Cell Mediated Hepatitis

doi: 10.1002/hep4.1584

Figure Lengend Snippet: Production of IFN‐γ is required for the sensitization of LXRα‐KI mice to ConA‐induced hepatitis. (A,B) Female WT and LXRα‐KI mice received a tail‐vein injection of 200 μg anti‐IFN‐γ antibody or the control isotype IgG 1 hour before the ConA (10 mg/kg) injection. The mice were sacrificed 24 hours after the ConA injection. (A) Liver histology with the quantification of necrotic area shown on the right. (B) Serum levels of ALT and AST (n = 4‐5 per group). Data are presented as mean ± SEM. * P < 0.05, ** P < 0.01.

Article Snippet: For in vivo neutralization of IFN‐γ, mice were injected intravenously with 200 μg InVivoMAb anti‐mouse IFN‐γ or the isotype control IgG (see Supporting Table ) from Bio X Cell (West Lebanon, NH) 1 hour before the ConA injections.

Techniques: Injection, Control

Journal: Cell Reports

Article Title: Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19

doi: 10.1016/j.celrep.2021.109798

Figure Lengend Snippet:

Article Snippet: Mouse anti-Human IgG2 Fc, HRP conjugate , Southern Biotech , Cat# 9070-05, RRID: AB_2796633.

Techniques: Control, Clinical Proteomics, Recombinant, Protease Inhibitor, Blocking Assay, Plasmid Preparation, Extraction, Real-time Polymerase Chain Reaction, Multiplex Assay, Enzyme-linked Immunosorbent Assay, Amplification, Polymer, Staining, RNA Sequencing, Activation Assay, Software, Luminex

Journal: Frontiers in Immunology

Article Title: The monocyte-derived cytokine response in whole blood from preterm newborns against sepsis-related bacteria is similar to term newborns and adults

doi: 10.3389/fimmu.2024.1353039

Figure Lengend Snippet: The production of TNF-α and IL-6 by term neonatal and adult WB shows a high degree of inter-individual variation. WB from term cord blood (term, N=11-17) and healthy adults (adult, N=11-18) was incubated with (A, B) LPS, Pam3Cys4K or R848 or with (C, D) E. coli , S. agalactiae (GBS), S. aureus or S. epidermidis (CNS) bacteria for 5h and the production of TNF-α and IL-6 was measured. (E) The inter-individual variation in production of TNF-α and IL-6 between individuals was determined for WB from term cord blood and healthy adults (N=11-18) for LPS (100 ng/mL), Pam3Cys4K (10 μg/mL) or R848 (10 μM) or bacteria (10 5 CFU/well). Cytokine concentrations are shown in pg/mL. CFU, colony-forming units.

Article Snippet: Biotin Mouse anti-Human TNF-α detection antibody (BD PharmingenTM), Biotin Mouse Anti-Human IL-6 detection antibody (eBioscienceTM) or Biotin mouse anti-Human IL-1β detection antibody (R&D Systems) was added as secondary antibody.

Techniques: Incubation, Bacteria

Journal: Frontiers in Immunology

Article Title: The monocyte-derived cytokine response in whole blood from preterm newborns against sepsis-related bacteria is similar to term newborns and adults

doi: 10.3389/fimmu.2024.1353039

Figure Lengend Snippet: Preterm neonatal WB produces lower levels of IL-6 and similar levels of TNF-α compared to term neonatal WB. Whole blood from preterm cord blood (preterm, N=8-10), term cord blood (term, N=17) and healthy adults (adult, N=17-21) was incubated with TLR ligands LPS (100 ng/mL), Pam3Cys4K (10 μg/mL) or R848 (10 μM) or with E. coli , S. agalactiae (GBS), S. aureus or S. epidermidis (CNS) bacteria (10 5 CFU/well) for 5h and the production of (A, B) TNF-α, (C, D) IL-6 and (E, F) IL-1β was measured. (G-I) The inter-individual variation in production of (G) TNF-α, (H) IL-6 and (I) IL-1β between individuals was determined for preterm cord blood (N=8-10). Cytokine concentrations are shown in log-transformed pg/mL. The dotted line indicates the limit of detection. CV = coefficiency of variation. * = P<0.05. ** = P<0.01. *** = P<0.001.

Article Snippet: Biotin Mouse anti-Human TNF-α detection antibody (BD PharmingenTM), Biotin Mouse Anti-Human IL-6 detection antibody (eBioscienceTM) or Biotin mouse anti-Human IL-1β detection antibody (R&D Systems) was added as secondary antibody.

Techniques: Incubation, Bacteria, Transformation Assay